The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients

BackgroundRegular follow-up care after kidney transplantation is performed in transplant centers together with local nephrologist practices in Germany. Patients after kidney transplantation have to fulfill many tasks and manage their disease, follow a complex therapeutic regimen, communicate with th...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Schiffer, Lars Pape, Julia K. Wolff, Raoul Gertges, Vanessa Visconti, Karen Reichert, Anja Pfau, Anne Dieterle, Katja Sauerstein, Andreas Kribben, Kristina Boss, Sinem Karaterzi, Felix Nensa, Philipp Winneckens, Mario Cypko, Wiebke Duettmann, Bianca Zukunft, Eva Schrezenmeier, Marcel G. Naik, Fabian Halleck, Roland Roller, Sebastian Möller, Oliver Amft, Klemens Budde
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Nephrology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneph.2025.1591962/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218196316979200
author Mario Schiffer
Lars Pape
Julia K. Wolff
Julia K. Wolff
Raoul Gertges
Vanessa Visconti
Karen Reichert
Anja Pfau
Anne Dieterle
Katja Sauerstein
Andreas Kribben
Kristina Boss
Sinem Karaterzi
Felix Nensa
Philipp Winneckens
Mario Cypko
Mario Cypko
Wiebke Duettmann
Bianca Zukunft
Eva Schrezenmeier
Marcel G. Naik
Fabian Halleck
Roland Roller
Sebastian Möller
Sebastian Möller
Oliver Amft
Oliver Amft
Klemens Budde
author_facet Mario Schiffer
Lars Pape
Julia K. Wolff
Julia K. Wolff
Raoul Gertges
Vanessa Visconti
Karen Reichert
Anja Pfau
Anne Dieterle
Katja Sauerstein
Andreas Kribben
Kristina Boss
Sinem Karaterzi
Felix Nensa
Philipp Winneckens
Mario Cypko
Mario Cypko
Wiebke Duettmann
Bianca Zukunft
Eva Schrezenmeier
Marcel G. Naik
Fabian Halleck
Roland Roller
Sebastian Möller
Sebastian Möller
Oliver Amft
Oliver Amft
Klemens Budde
author_sort Mario Schiffer
collection DOAJ
description BackgroundRegular follow-up care after kidney transplantation is performed in transplant centers together with local nephrologist practices in Germany. Patients after kidney transplantation have to fulfill many tasks and manage their disease, follow a complex therapeutic regimen, communicate with the transplant center and home nephrologists, and coordinate doctor appointments. It has been shown that mHealth solutions such as mobile phone applications (apps) can support patients in their self-management. However, stand-alone apps have limitations and ideally, the mHealth solutions are embedded in a holistic treatment approach, including healthcare professionals.MethodsWe will conduct a 1-year, prospective, randomized, 2-armed, parallel group multicenter trial in three German Kidney Transplant Centers (KTCs) to demonstrate that additional and continuous interventional telemedical management will improve health after kidney transplantation in patients of all ages. Therefore, a composite endpoint of seven key outcome variables [fewer hospitalizations, shorter length of hospitalization, less development of de novo donor-specific antibody (DSA), better medication adherence, lower tacrolimus intra-patient variability, better blood pressure control, and better renal function after kidney transplantation]was defined. All the patients will receive the same routine post-transplant aftercare. The patients in the interventional arm will receive additional predefined telemedical management, including regular telemedicine visits and automatic bidirectional data transfer (e.g., vital signs, wellbeing, medication plan, and laboratory data together with a chat option) between the patient at home and the KTC through a certified smartphone app. If necessary, a home nephrologist can be included in the automatic data transfer. In the interventional arm, the iBox score will be used to better detect patients at risk for early graft failure and drug-drug interactions will be regularly checked with certified software.DiscussionThe study aims to prolong patient and graft survival through additional telemedical services in order to reduce avoidable hospitalizations, improve treatment of co-morbidities, and improve adherence through patient empowerment, which should result in lower health care costs, and better quality of life of patients after kidney transplantation.Clinical Trial RegistrationClinicalTrials.gov, identifier NCT05897047.
format Article
id doaj-art-7ec55b75aec44dd3a7dab16c404ea732
institution OA Journals
issn 2813-0626
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nephrology
spelling doaj-art-7ec55b75aec44dd3a7dab16c404ea7322025-08-20T02:07:51ZengFrontiers Media S.A.Frontiers in Nephrology2813-06262025-06-01510.3389/fneph.2025.15919621591962The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipientsMario Schiffer0Lars Pape1Julia K. Wolff2Julia K. Wolff3Raoul Gertges4Vanessa Visconti5Karen Reichert6Anja Pfau7Anne Dieterle8Katja Sauerstein9Andreas Kribben10Kristina Boss11Sinem Karaterzi12Felix Nensa13Philipp Winneckens14Mario Cypko15Mario Cypko16Wiebke Duettmann17Bianca Zukunft18Eva Schrezenmeier19Marcel G. Naik20Fabian Halleck21Roland Roller22Sebastian Möller23Sebastian Möller24Oliver Amft25Oliver Amft26Klemens Budde27Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Pediatrics II, University Hospital of Essen, University of Duisburg-Essen, Essen, GermanyInstitut für Gesundheits- und Sozialforschung (IGES) Institute, Berlin, GermanyDepartment of Prevention Research and Social Medicine, Institute for Community Medicine, University Medicine Greifswald, Greifswald, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, GermanyDepartment of Nephrology, University Hospital of Essen, University of Duisburg-Essen, Essen, GermanyDepartment of Nephrology, University Hospital of Essen, University of Duisburg-Essen, Essen, GermanyInstitute for Artificial Intelligence in Medicine (IKIM), University Hospital Essen, Essen, GermanyInstitute for Artificial Intelligence in Medicine (IKIM), University Hospital Essen, Essen, GermanyInstitute for Artificial Intelligence in Medicine (IKIM), University Hospital Essen, Essen, GermanyIntelligent Embedded Systems, University of Freiburg, Freiburg, GermanyHahn-Schickard, Freiburg, GermanyDepartment of Nephrology, Charité, Berlin, GermanyDepartment of Nephrology, Charité, Berlin, GermanyDepartment of Nephrology, Charité, Berlin, GermanyDepartment of Nephrology, Charité, Berlin, GermanyDepartment of Nephrology, Charité, Berlin, Germany0German Research Center for Artificial Intelligence (DFKI), Berlin, Germany0German Research Center for Artificial Intelligence (DFKI), Berlin, Germany1Technische Universität Berlin, Berlin, GermanyIntelligent Embedded Systems, University of Freiburg, Freiburg, GermanyHahn-Schickard, Freiburg, GermanyDepartment of Nephrology, Charité, Berlin, GermanyBackgroundRegular follow-up care after kidney transplantation is performed in transplant centers together with local nephrologist practices in Germany. Patients after kidney transplantation have to fulfill many tasks and manage their disease, follow a complex therapeutic regimen, communicate with the transplant center and home nephrologists, and coordinate doctor appointments. It has been shown that mHealth solutions such as mobile phone applications (apps) can support patients in their self-management. However, stand-alone apps have limitations and ideally, the mHealth solutions are embedded in a holistic treatment approach, including healthcare professionals.MethodsWe will conduct a 1-year, prospective, randomized, 2-armed, parallel group multicenter trial in three German Kidney Transplant Centers (KTCs) to demonstrate that additional and continuous interventional telemedical management will improve health after kidney transplantation in patients of all ages. Therefore, a composite endpoint of seven key outcome variables [fewer hospitalizations, shorter length of hospitalization, less development of de novo donor-specific antibody (DSA), better medication adherence, lower tacrolimus intra-patient variability, better blood pressure control, and better renal function after kidney transplantation]was defined. All the patients will receive the same routine post-transplant aftercare. The patients in the interventional arm will receive additional predefined telemedical management, including regular telemedicine visits and automatic bidirectional data transfer (e.g., vital signs, wellbeing, medication plan, and laboratory data together with a chat option) between the patient at home and the KTC through a certified smartphone app. If necessary, a home nephrologist can be included in the automatic data transfer. In the interventional arm, the iBox score will be used to better detect patients at risk for early graft failure and drug-drug interactions will be regularly checked with certified software.DiscussionThe study aims to prolong patient and graft survival through additional telemedical services in order to reduce avoidable hospitalizations, improve treatment of co-morbidities, and improve adherence through patient empowerment, which should result in lower health care costs, and better quality of life of patients after kidney transplantation.Clinical Trial RegistrationClinicalTrials.gov, identifier NCT05897047.https://www.frontiersin.org/articles/10.3389/fneph.2025.1591962/fullkidney transplantationaftercarepatient empowermentAPPrandomized controlled trial (RCT)
spellingShingle Mario Schiffer
Lars Pape
Julia K. Wolff
Julia K. Wolff
Raoul Gertges
Vanessa Visconti
Karen Reichert
Anja Pfau
Anne Dieterle
Katja Sauerstein
Andreas Kribben
Kristina Boss
Sinem Karaterzi
Felix Nensa
Philipp Winneckens
Mario Cypko
Mario Cypko
Wiebke Duettmann
Bianca Zukunft
Eva Schrezenmeier
Marcel G. Naik
Fabian Halleck
Roland Roller
Sebastian Möller
Sebastian Möller
Oliver Amft
Oliver Amft
Klemens Budde
The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
Frontiers in Nephrology
kidney transplantation
aftercare
patient empowerment
APP
randomized controlled trial (RCT)
title The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
title_full The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
title_fullStr The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
title_full_unstemmed The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
title_short The SmartNTx-study: a prospective, randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
title_sort smartntx study a prospective randomized controlled trial to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients
topic kidney transplantation
aftercare
patient empowerment
APP
randomized controlled trial (RCT)
url https://www.frontiersin.org/articles/10.3389/fneph.2025.1591962/full
work_keys_str_mv AT marioschiffer thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT larspape thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT juliakwolff thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT juliakwolff thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT raoulgertges thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT vanessavisconti thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT karenreichert thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT anjapfau thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT annedieterle thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT katjasauerstein thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT andreaskribben thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT kristinaboss thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sinemkaraterzi thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT felixnensa thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT philippwinneckens thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT mariocypko thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT mariocypko thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT wiebkeduettmann thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT biancazukunft thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT evaschrezenmeier thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT marcelgnaik thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT fabianhalleck thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT rolandroller thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sebastianmoller thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sebastianmoller thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT oliveramft thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT oliveramft thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT klemensbudde thesmartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT marioschiffer smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT larspape smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT juliakwolff smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT juliakwolff smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT raoulgertges smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT vanessavisconti smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT karenreichert smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT anjapfau smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT annedieterle smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT katjasauerstein smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT andreaskribben smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT kristinaboss smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sinemkaraterzi smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT felixnensa smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT philippwinneckens smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT mariocypko smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT mariocypko smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT wiebkeduettmann smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT biancazukunft smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT evaschrezenmeier smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT marcelgnaik smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT fabianhalleck smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT rolandroller smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sebastianmoller smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT sebastianmoller smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT oliveramft smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT oliveramft smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients
AT klemensbudde smartntxstudyaprospectiverandomizedcontrolledtrialtoinvestigateadditionalinterventionaltelemedicalmanagementversusstandardaftercareinkidneytransplantrecipients